While filming in North Africa in 2005, chef Andrew Zimmern was caught off guard by a painful, lingering condition that, as of ...

After 27 years in business, Cytokinetics hopes to pit its own cardiac myosin inhibitor against one it initially developed—now owned by Bristol Myers Squibb—in a market worth billions. Aficamten has a ...

The recall is part of the FDA's active investigation into frozen shrimp products that could potentially be contaminated with ...

Slated for a Dec. 26 decision on Cytokinetics’ aficamten, the FDA has delivered an early Christmas present, awarding the South San Francisco biotech its first U.S. nod since its 1997 founding. | ...

APM Terminals and Barging Marine Solutions Limited have signed an exclusive lease agreement until September 2031 to increase ...

With an EV, you're unlikely to achieve the stated mileage unless you adjust your driving habits and learn the subtleties of ...

Virtual cells can teach us cellular biology. Virtual patients will teach us why therapies succeed or fail. Precision medicine will be won at that level.

With the passing of Professor Adamu Baikie on Friday, 12, 2025, Nigeria and the broader African academic community have lost a true architect of modern education. He was ...

Newer therapies improve inflammatory rosacea, yet additional research is needed to help clinicians manage vascular, ...

Bristol-Myers Squibb remains a contrarian dividend Buy, despite the overbought technical indicators and growth headwinds.

Big Pharma-backed Aktis Oncology has announced plans to go public, in the latest encouraging sign for those betting on a ...